Published in Oncotarget on June 20, 2015
Superior efficacy of co-treatment with the dual PI3K/mTOR inhibitor BEZ235 and histone deacetylase inhibitor Trichostatin A against NSCLC. Oncotarget (2016) 0.79
Stereotactic body radiation therapy induces fast tumor control and symptom relief in patients with iliac lymph node metastasis. Sci Rep (2016) 0.75
Volumetric modulated arc therapy for thoracic node metastases: a safe and effective treatment for a neglected disease. Oncotarget (2016) 0.75
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Res Rep Urol (2016) 0.75
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes. Oncotarget (2016) 0.75
Stereotactic body radiation therapy for patients with recurrent pancreatic adenocarcinoma at the abdominal lymph nodes or postoperative stump including pancreatic stump and other stump. Onco Targets Ther (2016) 0.75
New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer (2009) 77.71
Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA (2010) 10.97
Regional lymph node classification for lung cancer staging. Chest (1997) 5.13
Combined chemoradiotherapy regimens of paclitaxel and carboplatin for locally advanced non-small-cell lung cancer: a randomized phase II locally advanced multi-modality protocol. J Clin Oncol (2005) 2.98
Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys (2010) 2.84
Second-line or subsequent systemic therapy for recurrent or progressive non-small cell lung cancer: a systematic review and practice guideline. J Thorac Oncol (2006) 2.66
Dose-limiting toxicity after hypofractionated dose-escalated radiotherapy in non-small-cell lung cancer. J Clin Oncol (2013) 1.78
Local recurrence following initial resection of NSCLC: salvage is possible with radiation therapy. Cancer J (2006) 1.76
Stereotactic body radiation therapy for patients with lung cancer previously treated with thoracic radiation. Int J Radiat Oncol Biol Phys (2010) 1.58
Locally recurrent non-small-cell lung cancer after complete surgical resection. Mayo Clin Proc (1992) 1.57
Reirradiation and stereotactic radiotherapy for tumors in the lung: dose summation and toxicity. Radiother Oncol (2013) 1.48
Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys (2001) 1.42
Central-airway necrosis after stereotactic body-radiation therapy. N Engl J Med (2012) 1.27
Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer (1995) 1.27
Effects of postoperative mediastinal radiation on completely resected stage II and stage III epidermoid cancer of the lung. The Lung Cancer Study Group. N Engl J Med (1986) 1.11
Three-dimensional conformal radiotherapy for locoregionally recurrent lung carcinoma after external beam irradiation: a prospective phase I-II clinical trial. Int J Radiat Oncol Biol Phys (2003) 1.09
Adjuvant radiotherapy in non-small cell lung cancer with pathological stage I: definitive results of a phase III randomized trial. Radiother Oncol (2002) 1.09
Toxicity after reirradiation of pulmonary tumours with stereotactic body radiotherapy. Radiother Oncol (2011) 1.08
Stereotactic ablative radiotherapy for reirradiation of locally recurrent lung tumors. J Thorac Oncol (2012) 1.08
Prognostic factors in surgically resected N2 non-small cell lung cancer: the importance of patterns of mediastinal lymph nodes metastases. Eur J Cardiothorac Surg (2005) 1.04
Long-term results of high-dose conformal radiotherapy for patients with medically inoperable T1-3N0 non-small-cell lung cancer: is low incidence of regional failure due to incidental nodal irradiation? Int J Radiat Oncol Biol Phys (2005) 1.01
Simultaneous chemoradiotherapy compared with radiotherapy alone after induction chemotherapy in inoperable stage IIIA or IIIB non-small-cell lung cancer: study CTRT99/97 by the Bronchial Carcinoma Therapy Group. J Clin Oncol (2006) 0.98
Metastatectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: systematic review and analysis of reported cases. Lung Cancer (2011) 0.94
External beam radiation therapy alone for loco-regional recurrence of non-small-cell lung cancer after complete resection. Lung Cancer (1999) 0.94
Thoracic reirradiation for symptomatic relief after prior radiotherapeutic management for lung cancer. Am J Clin Oncol (2000) 0.94
Three-dimensional conformal radiation may deliver considerable dose of incidental nodal irradiation in patients with early stage node-negative non-small cell lung cancer when the tumor is large and centrally located. Radiother Oncol (2007) 0.93
Should patients with post-resection locoregional recurrence of lung cancer receive aggressive therapy? Int J Radiat Oncol Biol Phys (1992) 0.89
Comparative research on the efficacy of CyberKnife® and surgical excision for Stage I hepatocellular carcinoma. Onco Targets Ther (2013) 0.89
Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis. Acta Oncol (2008) 0.89
Stereotactic body radiation therapy using the CyberKnife(®) system for patients with liver metastases. Onco Targets Ther (2014) 0.86
Radiotherapy for locoregional recurrent tumors after resection of non-small cell lung cancer. Lung Cancer (1998) 0.86
Local recurrence after complete resection for non-small-cell carcinoma of the lung. Significance of local control by radiation treatment. J Thorac Cardiovasc Surg (1994) 0.86
Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors. Radiother Oncol (2014) 0.84
Patterns of failure after resection of non-small-cell lung cancer: implications for postoperative radiation therapy volumes. Int J Radiat Oncol Biol Phys (2006) 0.83
Thoracic re-irradiation using stereotactic body radiotherapy (SBRT) techniques as first or second course of treatment. Radiother Oncol (2014) 0.83
Identification of subsets of patients with favorable prognosis after recurrence in completely resected non-small cell lung cancer. Ann Surg Oncol (2014) 0.83
A retrospective quality of life analysis using the Lung Cancer Symptom Scale in patients treated with palliative radiotherapy for advanced nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys (1997) 0.82
Incidental irradiation of nodal regions at risk during limited-field radiotherapy (RT) in dose-escalation studies in nonsmall cell lung cancer (NSCLC). Enough to convert no-elective into elective nodal irradiation (ENI)? Radiother Oncol (2004) 0.81
Radiation therapy for postoperative local-regionally recurrent lung cancer. Int J Radiat Oncol Biol Phys (1980) 0.81
The spread of metastatic lymph nodes to the mediastinum from left upper lobe cancer: results of superior mediastinal nodal dissection through a median sternotomy. Eur J Cardiothorac Surg (2006) 0.80
Clinical observation on the efficacy of CyberKnife for primary or metastatic retroperitoneal tumours. Eur J Cancer Care (Engl) (2013) 0.77
Thoracic irradiation for patients with resected non-small cell lung cancer: adjuvant or salvage? Cancer J (2006) 0.76
Targeting brain metastases in ALK-rearranged non-small-cell lung cancer. Lancet Oncol (2015) 1.00
Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma. Onco Targets Ther (2015) 0.81
ASTRO APEx(®) and RO-ILS™ are applicable to medical malpractice in radiation oncology. Future Oncol (2016) 0.76
Stereotactic radiation therapy for oligometastases or oligorecurrence within mediastinal lymph nodes. Oncotarget (2016) 0.75
A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Res Rep Urol (2016) 0.75
Systemic therapy for echinoderm microtubule-associated protein-like 4 anaplastic lymphoma kinase non-small cell lung cancer brain metastases. J Thorac Dis (2016) 0.75
Oncology training programs: are we doing comparative effectiveness research justice? J Comp Eff Res (2013) 0.75